SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-009668
Filing Date
2016-11-08
Accepted
2016-11-08 15:13:06
Documents
55
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cerc-20160930x10q.htm 10-Q 1132299
2 EX-10.01 cerc-20160930ex10010783c.htm EX-10.01 829782
3 EX-10.01.01 cerc-20160930ex100101d97.htm EX-10.01.01 15102
4 EX-31.1 cerc-20160930ex31124e7af.htm EX-31.1 17576
5 EX-31.2 cerc-20160930ex31250f970.htm EX-31.2 17540
6 EX-32.1 cerc-20160930ex3214ad3a5.htm EX-32.1 14510
7 GRAPHIC cerc20160930ex10010783c001.jpg GRAPHIC 29678
8 GRAPHIC cerc20160930ex10010783c002.jpg GRAPHIC 5417
  Complete submission text file 0001558370-16-009668.txt   5631647

Data Files

Seq Description Document Type Size
9 EX-101.INS cerc-20160930.xml EX-101.INS 897768
10 EX-101.SCH cerc-20160930.xsd EX-101.SCH 45976
11 EX-101.CAL cerc-20160930_cal.xml EX-101.CAL 31062
12 EX-101.DEF cerc-20160930_def.xml EX-101.DEF 155714
13 EX-101.LAB cerc-20160930_lab.xml EX-101.LAB 406332
14 EX-101.PRE cerc-20160930_pre.xml EX-101.PRE 273953
Mailing Address 400 E. PRATT ST. SUITE 606 BALTIMORE MD 21202
Business Address 400 E. PRATT ST. SUITE 606 BALTIMORE MD 21202 410-522-8707
Cerecor Inc. (Filer) CIK: 0001534120 (see all company filings)

IRS No.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37590 | Film No.: 161981054
SIC: 2834 Pharmaceutical Preparations